Abiopharma

🔍 Altman Peter (Director)

Company: BioCardia, Inc. (BCDA)

Report Date: 2026-03-24

Detailed Transactions and Holdings:

• Acquired 600 shares of Common Stock at $1.24 per share (Direct)
  Date: 2026-03-24 | Code: P | equity_swap_involved: 0 | shares_owned_after: 274,466.00 | transaction_form_type: 4 | Footnotes: F1, F1
• Acquired 300 shares of Common Stock at $1.22 per share (Direct)
  Date: 2026-03-25 | Code: P | equity_swap_involved: 0 | shares_owned_after: 274,766.00 | transaction_form_type: 4 | Footnotes: F2, F2

Footnotes:

• F1: This transaction was executed in multiple trades ranging from $1.24 to $1.26 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price.
• F2: This transaction was executed in multiple trades ranging from $1.19 to $1.25 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price.